Intravenous Ondansetron in Pregnancy and Risk of Congenital Malformations

This pharmacoepidemiology study uses Medicaid data to estimate associations between first-trimester use of intravenous ondansetron and risk of cardiac malformations and oral cleft in children of exposed mothers.

Shranjeno v:
Bibliografske podrobnosti
izdano v:JAMA
Main Authors: Huybrechts, Krista F., Hernandez-Diaz, Sonia, Straub, Loreen, Gray, Kathryn J., Zhu, Yanmin, Mogun, Helen, Bateman, Brian T.
Format: Artigo
Jezik:Inglês
Izdano: American Medical Association 2020
Teme:
Research Letter
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6865841/
https://ncbi.nlm.nih.gov/pubmed/31730152
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jama.2019.18587
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki